MAIA Biotechnology, Inc. is a targeted therapy, immuno-oncology company focused on the development and commercialization of potential first-in-class drugs with novel mechanisms of action that are intended to meaningfully improve and extend the lives of people with cancer. Our lead program is ateganosine (THIO), a potential first-in-class cancer telomere targeting agent in clinical development for the treatment of telomerase-positive cancer cells.
Company Profile
Latest Presentation
Industry Classifications
Sector:
Oncology
Industry:
Biotechnology
Contact Information
Investor Relations
T: 872-270-3518
ir@maiabiotech.com
Company Contact
MAIA Biotechnology, Inc.
444 West Lake Street
Suite 1700
Chicago, IL 60606
T: 312-416-8592
info@maiabiotech.com